logo
logo
  • Company
  • People & History
  • Global Presence
  • Products & Services
  • Contact

Sustainability Report FY23-24

March 6, 2025Uncategorized


by handyland

Optimus Annual ESG Databook


by handyland

Anjan Drug Annual ESG Databook


by handyland

Customer Health & Safety Policy

August 2, 2024PolicyUncategorized


by handyland

Code of Conduct

July 24, 2024PolicyUncategorized


by handyland

Sustainability Policy

July 2, 2024PolicyUncategorized


by handyland

Occupational Health and Safety Policy

June 11, 2024PolicyUncategorized


by handyland

Corporate Social Responsibility Policy

May 30, 2024PolicyUncategorized


by handyland

Human Rights Policy

May 20, 2024PolicyUncategorized


by handyland

Supplier Code of Conduct

April 2, 2024PolicyUncategorized


by handyland

Sustainability Report FY22 -23


by handyland

Annual Returns 2022 - 2023


by handyland

Board Diversity Policy

March 4, 2024PolicyUncategorized


by handyland

Whistleblower Policy

February 12, 2024PolicyUncategorized


by handyland

Equal Opportunity Employer and Anti-Harassment Policy

January 2, 2024PolicyUncategorized


by handyland

CSR Policy

June 2, 2023Policy


by handyland

HBL - Sekhmet Pharmaventures appoints Khubchandani as MD


by handyland

ET - PAG-led Sekhmet Pharmaventures announces the hiring of Anil Khubchandani as MD and CEO


by handyland

BW - Sekhmet Pharmaventures Onbaords Anil Khubchandani As The New MD And CEO


by handyland

ET - PAG-led Sekhmet Pharmaventures announces the hiring of Anil Khubchandani as MD and CEO


by handyland

The Hindu - Anil Khubchandani appointed as MD, CEO of Sekhmet Pharmaventures


by handyland

Sekhmet Pharmaventures buys stake in Hyd-based Optimus Group


by handyland

CCI clears deal involving Sekhmet Pharmaventures, Optimus Drugs


by handyland

PAG, Partners to Acquire Controlling Stake in Optimus Drugs For Rs 2,000 Crore

May 15, 2022Uncategorized


by handyland

PAG invests Rs 2,000 crore in Optimus Drugs for controlling stake

May 11, 2022Uncategorized


by handyland

PAG consortium to acquire controlling stake in Optimus group firms

May 11, 2022Uncategorized


by handyland

PAG-led platform Gamot buys 70% in Chennai-based Anjan Drug

October 12, 2020Uncategorized


by handyland

PAG-led consortium to acquire majority stake in Anjan Drug

October 12, 2020Uncategorized


by handyland

Recent Posts

  • Sustainability Report FY23-24
  • Optimus Annual ESG Databook
  • Anjan Drug Annual ESG Databook
  • Customer Health & Safety Policy
  • Code of Conduct

Recent Comments

No comments to show.

Archives

  • March 2025
  • August 2024
  • July 2024
  • June 2024
  • May 2024
  • April 2024
  • March 2024
  • February 2024
  • January 2024
  • June 2023
  • May 2023
  • September 2022
  • August 2022
  • May 2022
  • October 2020

Categories

  • Anti-Allergic
  • Anti-bacterial
  • Anti-biotic
  • Anti-coagulant
  • Anti-convulsant
  • Anti-Diabetic
  • Anti-Fibrinolytic
  • Anti-fibrotic
  • Anti-fungal
  • Anti-Inflammatory
  • Anti-viral
  • Antibiotic
  • Anticoagulant
  • Anticonvulsant
  • Antidiabetic
  • Antiparkinson
  • Antipsychotic
  • Bengin Prostatic Hyperplasia (BPH)
  • Biliary Cirrhosis
  • Choleretic agent
  • Covid – 19
  • Hypotension
  • Janus kinase (JAK) inhibitor
  • Lipid Management
  • Over active bladder
  • Proton Pump Inhibitor
  • Stroke and Systemic
  • Uncategorized

Links

  • Home
  • Company
  • People & History
  • Global Presence
  • Products & Services
  • Disclosures
  • Contact

Social

LinkedIn

Email

[email protected]

Phone

+91-22-45119882

Address

Sekhmet Pharmaventures Pvt Ltd
C-220, 2nd floor,
215 Atrium, Andheri Kurla Road,
Andheri East, Mumbai 400059

© 2022 Sekhmet Pharmaventures Pvt Ltd. All rights reserved. Built with Handyland